Strand Therapeutics

Drug Discovery · Boston, MA · Founded 2017 · Privately Held (backing)

Developer of a medicine infrastructure platform intended to create medicines that respond to disease signals in real-time. Strand Therapeutics is based in Boston, MA and was founded in 2017. It was valued at $571 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $256 million across 3 recorded rounds; the latest was a $153 million Series B in Aug 2025.

PMV mark · valuation
$571.0M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$255.6M
Last round
Later Stage VC (Series B)
Aug 2025

Who backs Strand Therapeutics?

30 investors
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Strand Therapeutics investors

30 investors are on record for Strand Therapeutics, including Creative Destruction Lab, MassChallenge, National Institutes of Health and Endless Frontier Labs. By type, the record holds 7 venture capital firms and 2 private equity firms. The Series B in Aug 2025 drew 13 investors.

Free account
More of Strand Therapeutics with a free account
  • ·The complete investor list: 30 names
  • ·Watch Strand Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 30 firms already write checks for companies like Strand Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View